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Review Article 
Diagnostic Imaging of Metastatic Cervical Lymph Nodes
Takashi NAKAMURA, Misa SUMI, Sato EIDA
Department of Radiology and Cancer Biology, Nagasaki University School of Dentistry
 The presence of lymph node metastasis in the neck in pa-
tients with cancer of the oral cavity or other head and neck 
regions is an important prognostic determinant in staging 
cancers and in planning radiotherapy of the cancer patients. 
We review recent advances in diagnostic imaging of metastatic 
lymph nodes in the neck of patients with extracranial head 
and neck squamous cell carcinoma, with the main emphasis on 
diagnostic performances of CT, sonography, and MR imaging. 
       ACTA MEDICA NAGASAKIENSIA 46: 1-8, 2001
Key Words: squamous cell carcinoma, neck, nodal metastasis, 
          CT, sonography, MRI
Introduction
 Staging of neck metastasis is a crucial step in man-
aging patients with head and neck squamous cell carci-
nomaThe presence of lymph node metastasis in the 
neck in patients with cancer of the oral cavity or other 
head and neck regions is an important prognostic de-
terminant in staging cancers and in planning radiother-
apy of the cancer patients. In this regard, the presence 
of a metastatic lymph node (s) in the ipsilateral or 
contralateral side of the neck, or both, reduces the 5-
year survival rate by about 50%(2). In general, a pa-
tient with head and neck squamous cell carcinoma and 
regional metastasis will be treated with irradiation of 
the neck, surgery, or both. Since nodal metastasis is a 
frequent event that impacts prognosis of patients, the 
necks of such patients will be treated electively when 
regional metastasis is likely, even if not detected clini-
cally. Thus, if the probability of nodal metastasis is re-
duced (i.e. more accurately diagnosed), the number of 
elective treatment will be reduced. It is, therefore, im-
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portant to assess as reliably as possible whether a pa-
tient has regional lymph node metastasis. 
 Several studies have attempted to establish diagnos-
tic criteria for differentiation of metastatic from non-
metastatic cervical lymph nodes in these patients(3.4). The 
development of imaging techniques such as helical CT, 
MR imaging, and high resolution sonography (4,-9) has 
improved the detection of metastatic cervical nodes in 
patients with head and neck cancer. Accordingly, sev-
eral studies have attempted to determine reliable crite-
ria for these techniques. 
 Increases in nodal size were found to be effective imag-
ing criteria for detection of metastatic cervical nodes 
with CT and MR imaging' 1,4). However, size determina-
tion alone is not effective enough for detecting metastatic 
nodes. Thereby, several studies have attempted to im-
prove the diagnostic accuracy by assessing the inter-
nal architecture of the node, and by using other tissue 
specific imaging techniques such as sonography-guided 
fine needle aspiration biopsy('). Here, we review imag-
ing techniques and criteria for detection of metastatic 
cervical lymph nodes from head and neck cancer.
Structure of lymph node
 The lymph node consists of four structural and func-
tional components (Fig. 1) : 1) the cortex with its ger-
minal center, where the B cell system develops; 2) the 
medullary zone, in which most of the plasma cells re-
side and the B cell system exerts its secretory function; 
3) the paracortex lying between the germinal centers, 
in which most T cells reside; and 4) the sinuses, which 
contain macrophages and other mononuclear phagocyte 
cells. 
 The capsule of the lymph node is interrupted at 
various parts by afferent lymphatics that bring lymph 
into the marginal sinus. The marginal sinus continues 
into cortical or trabecular sinuses that traverse the 
paracortex and then enter the medullary cords, where 
the sinus become wider and more tortuous (medullary 
sinus).
Fig. 1. Drawing of lymph node structures.
Fig. 2. 70-year-old man with squamous cell carcinoma of 
lower gingival. 
A, Axial CT shows reactive node (arrow) exhibiting hilar 
structure. Minimal axial diameter is 5 mm. 
B, Axial CT shows fused metastatic nodes (arrow).
 Almost all the blood vessels enter the lymph node 
through the hilum. The larger arterial branches initially 
run within the traneculae, and then they soon enter the 
medullary cords and supply their capillary networks. 
Then the arteries reach the cortex, where they distrib-
ute to capillary plexuses of the cortex parenchyma and 
germinal centers. In the paracortex, capillary branches 
give rise to the high endothelial venules, which are dis-
tinctive to this region and brings circulating lympho-
cytes, predominantly T cells, to the paracortex.
CT
 Recent focus has been placed, at least in part, on the 
development of a diagnostic strategy to differentiate 
effectively the metastatic from reactive nodes in pa-
tients with cancer. Indeed, patients with head and neck 
cancer are associated with substantial numbers of re-
active nodes along with metastatic nodes. CT imaging 
is most commonly used in surveying metastatic nodes 
in patients with head and neck cancer, since CT pro-
vides excellent information about the location, size and 
even internal architectures of the node"'''. 
 The hallmarks for the metastatic nodes are increase 
in short (or minimal) axial diameter of the node and/or 
rim enhancement of the node (central nodal necrosis) 
after contrast enhancement (Figs. 2-4)"'). Other criteria 
include the maximal axial diameter, the irregular en-
hancement due to tumor necrosis and the shape`". The
Fig. 3. 69-year-old man with squamous cell carci-
noma of tongue. Axial CT shows homogeneously en-
hanced metastatic nodes (arrows). Minimal axial di-
ameters are 10 mm (left) and 12 mm (right).
difference in criteria used accounts, in part, for the dif-
ference in the reported overall error. van den Brekel, 
et al. showed that the minimal axial diameter was the 
most accurate size criterion for predicting metastatic 
cervical nodes':'). They reported that a minimal axial 
diameter of 10 mm was the most effective size crite-
rion. However, this criterion provided an atmost
Fig. 4. 87-year-old woman with squamous cell carci-
noma of tongue. Axial CT shows metastatic node with 
rim enhancement (arrow). Minimal axial diameter is 
14 mm.
moderate performance in detecting metastatic cervical 
nodes, with 42% sensitivity and 99% specificity for as-
sessment per node and 89% sensitivity and 73% speci-
ficity per neck. More recent studies using the receiver 
operating characteristic curve (ROC) analysis demon-
strated that the CT performance for detecting metastatic 
nodes was moderate, with the area under the ROC curve 
(Az value) at 0.80-0.87 for varying combinations of 
size and internal architecture criteria of the node1''8) 
. These studies also showed that, when using a 10-mm 
size criteria, the CT had a negative predictive value of 
0.83 and positive predictive value of 0.50, and had a 
accuracy of 0.80. 
 Central nodal necrosis is considered to be a pathogno-
monic feature for metastatic nodes from head and neck 
squamous cell carcinomas. Central nodal necrosis occurs 
as cancer cells infiltrate into the medullary portion of 
the node to surpass the blood supply. Central nodal 
necrosis was reported to occur in 32% of metastatic 
nodes(3'. CT was shown to have a sensitivity of 74% 
and specificity of 94% for detecting central nodal ne-
crosis. Another study showed that CT was more effective 
than MR imaging in detecting central nodal necrosis('. 
 One of the most commonly accepted classifications 
of cervical nodes is that of the International Union 
Against Cancer (UICC)1i°'. However, the classification 
adopted by the Academy of Otolaryngology Head and 
Neck Surgery, where the nodes are classified into level 
I through level VV'), appears to be readily acceptable 
for clinicians, since such numeric classification is simple 
and useful for understanding recent management of
selective neck dissections. The image-based classifica-
tion originally proposed by Som, et al.( ̀ 2 is basically 
similar to this classic, pulpation-based numerical classi-
fication (Fig. 5). However, in the image-based classifi-
cation, nodes are classified with more in-deep defini-
tion, allowing reproducible identification of nodes using 
precise anatomical landmarks. Thus, except for nodes 
in the lowest levels of the neck, such as those in level 
VI and the subclavicular fossa, where CT imaging is 
disturbed by artifacts from the bone, the image-based 
classification may be relevant to the management of 
patients and dispensable for the palpation-based classi-
fication. 
 Introduction of helical CT can improve diagnostic per-
formance for detection of malignant nodes in the neck. In 
this context, Steinkamp, et al reported preliminarily 
that size criterion using the ratio of the maximum lon-
gitudinal diameter to maximum axial diameter yielded 
97% sensitivity and 97% specificity for metastatic lymph 
nodes from head and neck tumors"'). Helical CT tech-
nique allows displaying coronal, sagittal, axial, and par-
axial images of the node without increasing extra ex-
amination time. Therefore, helical CT technique could 
permit more precise assessment of topographical rela-
tionships of the node to vessels as well as volumetric 
assessment of enlarged nodes in the neck. 
 It was documented that metastatic and non-metastatic 
nodes in the subdigastric and submandibular regions,
Fig. 5. Drawing shows image-based classification by Som, et 
al. 12
which correspond to levels I and II of the neck, had axial 
diameters that were on average 1-2 mm larger than nodes 
in other levels'3'41. This could affect size criteria that yield 
compromising sensitivity and specificity in detecting 
metastatic nodes. Sumi, et al. showed that metastatic 
nodes in level II were on average 2-3 mm larger in 
minimal axial diameter than those in other levels (I, III, 
and IV) of the neck, but non-metastatic nodes were simi-
lar in size among these levels"). Consistent with the no-
tion proposed by preceding reports, they showed that the 
diagnostic performance of CT in detecting metastatic 
nodes was higher with nodes at level II than those at 
other levels. 
 Nodes in levels I and II of the neck receive lymphatic 
drainage from anterior facial structures and skin, the 
floor of the mouth, and the anterior oral cavity"'). Nodes 
in level II-IV receive lymphatic drainage from the parotid, 
retropharyngeal, and nodes in level IB. The nodal chain 
in levels II-IV serves as a common pathway for all lym-
phatics of the upper aerodigestive tract and neck. Thus, 
these drainage patterns result in different incidences of 
metastatic nodes in different levels of the neck. The 
incidence of adenopathic or enlarged nodes was higher 
in patients with pharyngeal cancer than those with oral 
cancer. Metastatic nodes from the oral cavity appear 
predominantly in levels IB and IIA. Level IA is a com-
mon site for metastasis from cancers in the lower gingiva, 
oral floor, and tongue. Cancers in the oral floor and 
tongue can metastasize to nodes in levels III and IV, 
but metastatic nodes in this level were uncommon from 
other oral cancers. In contrast, laryngeal and esophag-
eal cancers rarely metastasize to nodes in levels IA 
and IB. Levels VA, VB, and VI are uncommon sites for 
metastasis from head and neck cancers.
Sonography
 Sonographic evaluation of metastatic nodes is also 
based on assessment of the internal architecture of the 
node and size determination of the node, and abnormali-
ties in the metastatic node may be reflected by increased 
parenchymal echogenicity or loss of hilar echogenicity(5,15) 
In addition, the recent development of Doppler sonographic 
technology has shed light on the diagnostic significance 
of changes in nodal blood flow when differentiating 
. metastatic from non-metastatic nodes(ls_'9) 
 High-resolution sonography could be a tool for the 
detection of metastatic lymph nodes, and this was partly 
substantiated by the observation of Vassallo, et al., who 
showed that an increased transverse to longitudinal 
ratio and eccentric widening of the nodal cortex were 
useful structural parameters for differentiating benign
and malignant nodes". van den Brekel, et al!" and, later, 
Chikui, et al.(20) demonstrated that the minimal axial di-
ameter was the most accurate size criterion compared 
to the maximal axial diameter and the longitudinal di-
ameter. Similar to the assessment by CT, the best size 
criterion for metastatic nodes differed among levels of 
the neck; van den Brekel, et al!") and Yonetsu, et al,(") 
postulated that a minimal axial diameter of 7 mm for 
level II and 6 mm for the remainder of the neck provide 
the optimal compromise between sensitivity (67-87%) 
and specificity (72-89%). 
 Color Doppler sonography provides information about 
blood flow and morphology. The use of higher frequency 
transducers improves the ability to detect low-velocity 
signals from superficial organs. By analyzing the spec-
tral waveform, Steinkamp, et al .(21) and, more recently, 
Choi, et al!") appraised the clinical usefulness of color 
Doppler sonography for differentiating superficial lymph 
nodes involved in metastasis from those affected by 
benign diseases. They showed that the resistive index 
was significantly higher in the metastatic lymph nodes 
than in the benign lymph nodes, and they proposed 
that this difference was due to compression by tumor 
cells of vessels in the lymph node and/or tumor-evoked 
angiogenesis. However, vessels were dilated in the non-
metastatic lymph nodes. 
 Power Doppler sonography was first introduced by 
Rubin, et al .1211. It is essentially angle-independent and 
has a greater dynamic range than conventional color 
Doppler sonography, thus increasing sensitivity. This 
extended dynamic range enhances visualization of the 
microvascularity of the lymph nodes. Ariji, et al. was 
among the first who described the importance of ab-
normal blood flow patterns in differentiating metastatic 
from non-metastatic nodes in patients with head and 
neck cancer( 7). They classified nodal flows into three 
major types; 1) hilar, 2) parenchymal, and 3) no blood 
flow signals (Figs. 6-9). Power Doppler sonography was 
found to provide high levels of sensitivity (83%) and 
specificity (98%) in depicting metastatic lymph nodes, 
which was superior to those by lymph node size crite-
ria (transverse to longitudinal ratio, T/L ratio). Further-
more, they showed that a combination of the two 
sonographical criteria (parenchymal color signal and 
T / L ratio) improved the diagnostic accuracy (92% 
sensitivity and 100% specificity). 
 Chikui, et a1.(20) compared in a multivariate feature 
study the grey-scale and power Doppler sonographic 
parameters to show that, of the sonographic criteria 
advocated for metastatic or non-metastatic nodes, the 
presence or absence of hilar echogenicity, increases in 
short axis diameter, and the presence of normal hilar 
blood flow were the only sonographic features that
Fig. 6. 57-year-old man with squamous cell carcinoma of buccal mucosa. 
A, Grey-scale sonography of reactive node shows homogeneous echogenicity of the nodal parenchyma with hilar 
echogenicity. Minimal axial diameter is 8 mm. 
B, Power Doppler sonoography of the same node as that shown in panel A exhibits hilar blood flow signal.
Fig. 7. 63-year-old woman with squamous cell carcinoma of lower gingiva. 
A, Grey-scale sonography of metastatic node shows heterogeneous echogenicity of the nodal parenchyma. Note that 
no hilar echogenicity is detected. Minimal axial diameter is 8 mm. 
B, Power Doppler sonography of the same node as that shown in panel A exhibits multiple parenchymal blood flow signals.
Fig. 8. 77-year-old woman with squamous cell carcinoma of lower gingiva. 
A, Grey-scale sonography of metastatic node shows homogeneous echogenicity of the nodal parenchyma. Minimal 
axial diameter is 12 mm. 
B, Power Doppler sonography of the same node as that shown in panel A exhibits blood flow signals in the periph-
ery of the node.
Fig. 9. 49-year-old woman with squamous cell carcinoma of lower gingiva. 
A, Grey-scale sonography of metastatic node shows heterogeneous echogenicity of the nodal parenchyma. Minimal 
axial diameter is 9 mm. 
B, Power Doppler sonography of the same node as that shown in panel A exhibits no blood flow signal from the 
node.
were predictive of metastatic (increases in short axis 
length) or reactive nodes (the presence of normal hilar 
blood flow or hilar echoes, or both). 
 Compared with the single use of short axis diameter 
criteria, the combined use of the size and Doppler blood 
flow pattern criteria increased the diagnostic accuracy 
of sonography at all levels in the neck. Accordingly, 
the best cut-off values were improved to 6, 7, and 5 
mm for nodes at levels I, II, and III plus IV, respectively. 
In addition, the combined criteria yielded high sensi-
tivities ( >_ 89%) and specificities ( >_ 94%) `22'. 
 Most recently, Sumi, et al. compared the ability of 
sonography and CT to differentiate benign from malig-
nant cervical lymph nodes in patients with head and 
neck squamous cell carcinomas"'. ROC curve analysis 
showed that sonography provided greater diagnostic 
performance (power Doppler plus grey-scale, 0.97 and 
grey-scale, 0.95) than CT (0.87). ROC curve analysis 
also demonstrated that the greater ability of sonography 
to depict the internal architecture of the nodes com-
pared with CT significantly contributed to the better 
performance of sonography compared to CT in diag-
nosing metastatic nodes in the neck. However, size cri-
teria (minimal axis diameter) were equally predictive 
in sonography and CT. 
 Assessment of the intranodal blood flow patterns is 
also useful in monitoring malignant nodes after radia-
tion therapy. Ahuja et al showed, in their preliminary 
study, that a reduction in intranodal vascularity was 
detected and color Doppler sonographic parameters, such 
as resistive and pulsatility indices, had returned to lev-
els observed in benign nodes as early as 8 weeks after 
completion of treatment`25'. 
 The lack of requirement for radiation and low cost
may be major advantages of sonographic examination. 
Accumulating evidence indicates that sonography per-
forms better than CT in detecting metastatic nodes in 
patients with head and neck squamous cell carcinoma. 
Nevertheless, since sonographic examination takes much 
more time than CT, it may greatly diminish the value 
of sonography; in general, sonographic examination of 
the bilateral neck requires on average 10-fold much 
examination time`'. In addition, the CT examination is 
necessary for the detection of deep cervical nodes such 
as those in the retropharyngeal space. Therefore, it may 
be reasonable to perform sonographic examination for 
detailed study of suspected nodes in the neck, follow-
ing CT surveillance. 
 Sonography-guided fine-needle aspiration biopsy (FNAB) 
may be another adjunctive tool for a further increase in 
reliability and accuracy for the diagnosis of metastatic 
cervical nodes. A fundamental concept for sonography-
guided FNAB is to combine the high sensitivity of 
sonography and the high specificity of cytology. However, 
sonography-guided FNAB has been reported to have 
relatively low sensitivity (less than 77%), while the 
reported specificity is 100%`2".2". A combination of grey-
scale and Doppler sonographic criteria may be helpful in 
selecting nodes for sonography-guided FNAB. Contrast-
enhanced sonography, which has not yet been exten-
sively studied, may also be helpful for increasing the 
reliability of sonographic diagnosis of metastatic nodes.
MR imaging
 Since the early 1990s, MR imaging has been exten-
sively applied to diagnostic imaging of metastatic
cervical lymph nodes"". Despite the superior contrast 
resolution of MR over CT, the signal intensity of 
metastatic nodes does not differ significantly from that 
of benign nodes. Central nodal necrosis appears high 
in signal intensity on T2-weighted images and low in 
signal intensity on T1-weighted images. In general, 
however, the performance of MR imaging does not ex-
ceed that of CT in this aspect; for instance, MR imag-
ing criteria regarding the presence or absence of cen-
tral nodal necrosis yielded an accuracy of 86-87% with 
T1- or T2-weighted images, which was lower than that 
of CT (91-96%)(9). Gadolinium-enhanced fat-suppression 
techniques did not improve detection of central nodal 
necrosis. 
 A more recent study showed that CT performed 
slightly better than MR imaging, when size criteria 
and/or information on internal architectural abnor-
malities of the node on MR images was used for high-
lighting positive nodes('); they reported that Az values 
for combined information on size and internal architec-
tural abnormalities were 0.80 for CT and 0.75 for MR 
imaging. Information on extranodal cancer spread did 
not improve the performance of MR imaging for de-
tecting metastatic nodes(9). Use of specific techniques, 
such as diffusion-weighted imaging") and magnetiza-
tion transfer imaging(", may improve the performance. 
 Use of superparamagnetic contrast agents may be an 
alternative way for improving the performance of MR 
imaging in detecting metastatic nodes in the neck. 
Ultrasmall ion particles less than 20 nm in diameter 
are able to traverse across the capillary wall, enter the 
lymphatics, and subsequently are trapped by macro-
phages in the lymph node("). Normal nodes that have 
taken up ion particles reduce signal intensity, while 
metastatic nodes remain high in signal intensity due 
to replacement by cancer cells. Anzai, et al. reported in 
their preliminary study, that dextran-coated ultrasmall 
superparamagnetic ion oxide (USPIO) differentiated ef-
fectively metastatic from benign nodes in the neck of 
patients with extracranial head and neck cancer(31) 
More recent studies on patients with cancer in head 
and neck as well as other regions have extended the 
previous findings to show that sensitivity was 95-
100%, and specificity was 38-97% with USPIO(32-34)
Miscellaneous modalities
 Lastly, we should comment on recent advances of sin-
gle photon emission CT (SPECT) and positron emission 
CT (PET) for detection of metastatic nodes. Thallium 201 
(201 T1) and technetium-99m (99`nTc) hexakis-2-methoxy-
isobutyl-isonitrile (MIBI) are major SPECT agents. Uptake
of 201 TI depends on blood flow in the interstitial spaces 
and on the sodium-potassium pump in the cell mem-
brane. Valdes Olmos reported that 201T1-SPECT yielded 
71% sensitivity and 92% specificity for detection of 
metastatic cervical nodes in patients with head and neck 
squamous cell carcinoma and concluded that 201 Tl-
SPECT alone was not sensitive enough for staging of the 
neck"". To date, no extensive study using MIBI-SPECT 
has been reported with cervical lymph nodes, while MIBI-
SPECT provided low sensitivity in detecting axillary 
lymph nodes metastatic from breast cancer'36). 
 PET using 2-[18F]fluoro-2-deoxy-d-glucose (FDG) could 
be another functional imaging modality for detection 
of metastatic nodes. Malignant nodes have higher glu-
cose utilization than normal nodes. Accordingly, FDG-
PET might detect metastatic nodes that are negative 
with size criteria by MR imaging"'). However, metastatic 
nodes that contain large necrotic area are negative 
with FDG-PET criteria due to the low glycolytic activ-
ity of the necrotic material. FDG-PET criteria has not 
been well established, and poor accuracy of FDG-PET in 
visual interpretation of a lesion is frequently a problem. 
Other disadvantages of FDG-PET are limited clinical 
availability, low spatial resolution, and high cost. FDG-
PET provided better performance in detecting metastatic 
pelvic nodes in patients with cervical cancer compared 
to MR imaging, with a patient-based nodal staging by 
FDG-PET resulting in 91% sensitivity and 100% speci-
ficity, while 73% sensitivity and 83% specificity with 
MR imaging (38). Further studies are necessary to facili-
tate clinical application of FDG-PET for head and neck 
imaging.
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